Catalent
CTLT
#1835
Rank
NZ$20.12 B
Marketcap
NZ$110.90
Share price
0.00%
Change (1 day)
16.47%
Change (1 year)
Catalent is an American pharmaceutical contract research and development company.

EPS for Catalent (CTLT)

EPS in 2024 (TTM): NZ-$10.40

According to Catalent's latest financial reports the company's current EPS (TTM) is NZ-$11.06. In 2023 the company made an earnings per share (EPS) of NZ-$11.88 a decrease over its 2022 EPS that were of NZ$3.97.

EPS history for Catalent from 2014 to 2024

Annual EPS

Year EPS Change
2024 (TTM)NZ-$10.40-12.48%
2023NZ-$11.88-399.56%
2022NZ$3.97-30.58%
2021NZ$5.7179.67%
2020NZ$3.18114.12%
2019NZ$1.48-15%
2018NZ$1.7575.44%
2017NZ$1.00-22.97%
2016NZ$1.29-59.56%
2015NZ$3.20282.05%
2014NZ$0.84

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Supernus Pharmaceuticals
SUPN
NZ-$0.89-91.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Jazz Pharmaceuticals
JAZZ
NZ$0.80-107.27%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Aerie Pharmaceuticals
AERI
NZ-$1.31-88.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Intercept Pharmaceuticals
ICPT
NZ-$2.59-76.62%๐Ÿ‡บ๐Ÿ‡ธ USA